Cleerly LABS vs Us2.v2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Cleerly LABS specializes in the AI-powered analysis of coronary CT angiography (CCTA) to detect and characterize atherosclerosis and stenosis, focusing on coronary artery disease management. Conversely, Us2.v2 automates the interpretation of echocardiograms, providing comprehensive reports for a broader spectrum of cardiac conditions such as valvular disease and heart failure. The choice between these tools depends on whether the clinical need is for detailed coronary plaque assessment via CCTA or overall cardiac function and structural analysis via echocardiography.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) images to detect, quantify, and characterize atherosclerosis and stenosis. Us2.v2 automates the interpretation of echocardiograms, delivering a complete structured echo report.
Cleerly LABS focuses on assessing coronary plaque volume and type, stenosis detection and quantification, and ischemia detection (with an additional module) from CCTA. Us2.v2 automates the detection of cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease from echocardiograms.
Cleerly LABS integrates with PACS, RIS, and EHR systems via its Cleerly Proxy. Us2.v2 integrates seamlessly with existing PACS, CVIS, or EMR systems, supporting HL7 and DICOM SR.
Cleerly LABS aims to create a new standard of care for heart attack elimination through AI-powered cardiovascular imaging and personalized heart disease management. Us2.v2 explicitly states it reduces reporting time by up to 70% and increases daily scan throughput through 100% AI automation, eliminating manual frame selection and annotation.
More Comparisons
Backers
Who funded each tool's parent company.